Precision BioSciences, Inc. (DTIL)
7.80
-0.60
(-7.14%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -170.2% |
| December 31, 2025 | 56.27% |
| September 30, 2025 | -167.5K% |
| June 30, 2025 | -130.7K% |
| March 31, 2025 | -70.91K% |
| December 31, 2024 | -2.78K% |
| September 30, 2024 | -2.85K% |
| June 30, 2024 | 65.63% |
| March 31, 2024 | 48.84% |
| December 31, 2023 | -190.9% |
| September 30, 2023 | -92.30% |
| June 30, 2023 | -15.33% |
| March 31, 2023 | -158.9% |
| December 31, 2022 | -183.3% |
| September 30, 2022 | -213.1% |
| June 30, 2022 | -812.4% |
| Date | Value |
|---|---|
| March 31, 2022 | -849.2% |
| December 31, 2021 | -351.6% |
| September 30, 2021 | -46.93% |
| June 30, 2021 | 31.47% |
| March 31, 2021 | -114.3% |
| December 31, 2020 | -265.1% |
| September 30, 2020 | -353.3% |
| June 30, 2020 | -3.03K% |
| March 31, 2020 | -383.5% |
| December 31, 2019 | -320.7% |
| September 30, 2019 | -426.4% |
| June 30, 2019 | -360.7% |
| March 31, 2019 | -581.9% |
| December 31, 2018 | -312.6% |
| March 31, 2018 | -589.8% |
| December 31, 2017 | -484.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 23.59% |
| 4D Molecular Therapeutics, Inc. | -1.93K% |
| Agenus, Inc. | -1.64% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -101.4% |
| Return on Assets | -42.78% |
| Return on Invested Capital | -65.66% |
| Return on Net Operating Assets | -383.9% |